Rubedo Life Sciences
VerifiedRubedo Life Sciences mission is to treat age-related diseases to extend health-span targeting senescence and stem cells.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$160—240m (Dealroom.co estimates Apr 2024.)
Sunnyvale California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $0.0 | round | |
| investor investor investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
* | $40.0m | Series A | |
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about Rubedo Life Sciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.